• With $250 million, Peter Diamandis' new startup is all about taking stem cells from placentas

    6 monthes ago - By TechCrunch

    Stem cells derived from a human placenta hold the key to unlocking a myriad of potentials in regenerative medicine and are the focus of X-Prize and Singularity University founder Peter Diamandis' new endeavor.
    Called Celularity, the startup is a spinout from Celgene, a global biopharmaceutical company creating gene therapies. Diamandis teamed up with Dr. Robert Hariri, the founder of...
    Read more ...

     

  • Lydia raises $16.1 million to become the PayPal of mobile payments

    Lydia raises $16.1 million to become the PayPal of mobile payments

    6 monthes ago - By TechCrunch

    French startup Lydia is raising a $16.1 million round led by CNP Assurances with existing investors XAnge, New Alpha AM, Oddo BHF and Groupe Duval also participating.
    Lydia isn't the first startup that wants to replace PayPal, and also probably not the last one. But it's clear that the company is slowly becoming mainstream in France. The company first focused on...
    Read more ...

     

  • Celularity turns to placenta stem cells to try to extend life - CNET

    Celularity turns to placenta stem cells to try to extend life - CNET

    6 monthes ago - By CNET

    The company says it's found a way around the opposition to stem cell research by using postpartum placentas instead of embryos.
    Read more ...

     

  • Peter Diamandis Is the Latest Tech Futurist Betting on Stem Cells

    6 monthes ago - By Wired

    Founder of the X Prize is turning his attention to fighting the onset of old age, one stem cell at a time.
    Read more ...

     

  • A startup that wants to use stem cells to keep us living longer just raised $200 million

    A startup that wants to use stem cells to keep us living longer just raised $200 million

    6 monthes ago - By Business Insider

    Celularity is a New Jersey-based startup co-founded by X-Prize founder Dr. Peter Diamandis and ex-Celgene executive Dr. Bob Hariri.
    It has raised $200 million in funding for its stem-cell-based platform.
    The company is specifically using and storing placental stem cells for its regenerative medicine and cell therapy programs.
    The goal, Diamandis said, is "augmenting people's immunity to enable them to fight cancer and autoimmune disease."
    A startup that's using stem cells from placentas for various regenerative medicine and cell therapy treatments just raised another $200...
    Read more ...